Now that Baycol (cerivastatin) is off the market, patients are asking whether the other statins are safer.

Now that Baycol (cerivastatin) is off the market, patients are asking whether the other statins are safer.

The answer is yes.

The incidence of serious rhabdomyolysis was almost 10 times higher with Baycol than the other statins.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote